# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030502
Filing Date
2023-11-07
Accepted
2023-11-07 09:19:44
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | sava20230930_10q.htm iXBRL | 10-Q | 852349
2 | EXHIBIT 31.1 | ex_566477.htm | EX-31.1 | 14272
3 | EXHIBIT 31.2 | ex_566478.htm | EX-31.2 | 13877
4 | EXHIBIT 32.1 | ex_566479.htm | EX-32.1 | 7785
10 |  | a1.jpg | GRAPHIC | 60544
11 |  | a03.jpg | GRAPHIC | 49207
12 |  | a04.jpg | GRAPHIC | 44466
13 |  | cass01.jpg | GRAPHIC | 16219
14 |  | cass02.jpg | GRAPHIC | 20578
15 |  | chart_2.jpg | GRAPHIC | 71417
| Complete submission text file | 0001437749-23-030502.txt |  | 4697010

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | sava-20230930.xsd | EX-101.SCH | 39981
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | sava-20230930_cal.xml | EX-101.CAL | 29973
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | sava-20230930_def.xml | EX-101.DEF | 264484
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sava-20230930_lab.xml | EX-101.LAB | 224894
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sava-20230930_pre.xml | EX-101.PRE | 287483
59 | EXTRACTED XBRL INSTANCE DOCUMENT | sava20230930_10q_htm.xml | XML | 517472

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 231382027
SIC: 2834 Pharmaceutical Preparations